documents: FDA-2022-N-2390-0030

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-N-2390-0030 FDA FDA-2022-N-2390 Response from Vanda Pharmaceuticals Inc. Response to FDA CDER Other Response(s) 2023-10-19T04:00:00Z 2023 10 2023-10-19T04:00:00Z   2023-10-19T19:33:28Z   0 0 090000648610f7c8

Links from other tables